Piloting a Smartphone App to Improve Treatment Adherence Among South African Adolescents Living With HIV
- Sponsor
- Duke University
- Study ID
- NCT04661878
- Status
- Completed
Conditions
- Adolescent Behavior
- HIV Infections
Eligibility Criteria
- Sex
- ALL
- Age
- 15 Years - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- Social Support — BEHAVIORALThe app will provide opportunities for participants to interact with each other as well as trained peer mentors to receive and provide social support.
- Informational Resources — BEHAVIORALThe app will provide opportunities for participants to review HIV-related health information in engaging formats (e.g., activities, multi-media resources, and answer to users' health questions)
- Self-Monitoring and habit formation — BEHAVIORALThe app will provide opportunities for participants to track their treatment adherence and schedule tailored reminders.
- Goal setting and action planning — BEHAVIORALThe app will provide opportunities for participants to identify goals, select action items, and receive tailored feedback on the action plan.
Study Details
The overall goal of this pilot randomized-controlled trial (RCT) is to pilot MASI (MAsakhane Siphucule Impilo Yethu; Xhosa for "Let's empower each other and improve our health"), an ART adherence-supporting smartphone app with 50 adolescents and young adults living with HIV to assess its feasibility and acceptability and to explore preliminary effects on ART adherence and social support.
Key Dates
- Start date
- Jun 21, 2022
- Status verified
- Jun 2025
- Primary completion
- Mar 15, 2024
- Completion
- Apr 2, 2024
Study Design
- Enrollment
- 50 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: MASIParticipants randomized to the intervention condition will receive access to MASI, the smartphone app customized for this study. MASI is an adapted version of HealthMpowerment, a theory-based smartphone app with features including an anonymous interactive discussion forum, a medication and adherence tracker, a platform to ask questions to an expert, a section with engaging activities (including quizzes, self-assessments, and goal-setting activities), and a multi-media resource center.
- Active Comparator: Information-only version of MASIParticipants randomized to the control condition will an information-only version of MASI which will include the Resources feature and the home page.
Primary Outcome Measure
Intervention Feasibility: Number of Days Participants Log in to the App as Recorded by App Backend Paradata [ Time Frame: Months 1-3 ]
Related Studies
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruiting · University of California, San Francisco · San Francisco, California
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.Recruiting · Syneos Health · Wilmington, North Carolina
- Imaging Immune Activation in HIV by PET-MRPHASE2 · Recruiting · CellSight Technologies, Inc. · San Francisco, California
- ChangeGradients: Promoting Adolescent Health Behavior ChangeRecruiting · University of California, San Francisco · San Francisco, California